
Giannarelli Lab News & Awards
Faculty and trainees in the laboratory of Chiara Giannarelli, MD, PhD, are recognized for their innovative research. Read more about our accomplishments.
Team Awards
2024
Natalia Eberhardt, PhD
- Best Poster Presentation Award, 3rd Annual Retreat NYC Area
- Early Career Editorial Board (ECEB) member in the ATVB journal
- American Heart Association Research Post-Doctoral Supplement (2022/2024)
Dayasagar Das, PhD
- Outstanding Oral Presentation, Cardiovascular Research Centre Annual Symposium, NYU Langone Health
- SFRN REPAIR Fellowship, American Heart Association (2022-2024)
2023
Natalia Eberhardt, PhD
- ATVB Outreach Travel Grants for Early Career Investigators
- Nominated as a top candidate for the Blavatnik Family Foundation 2024 regional awards for young scientists by the NYU Office of the Provost
- Outstanding Presentation Award for “SARS-CoV-2 infection of human vessels triggers pro-atherogenic inflammatory responses” at the Cardiovascular Research Center Annual Symposium, NYU Grossman School of Medicine, New York, NY
2022
Letizia Amadori
- received the Best Oral Presentation Award - NYU Langone Cardiovascular Research Center Retreat, New York, NY
- recognized with Best Poster Award - NYU Langone Immunology Retreat, New York, NY
Natalia Eberhardt
- awarded the Atherosclerosis, Thrombosis and Vascular Biology Council Scientific Sessions Travel Grant for Early Career Investigators, Chicago, IL
- awarded AHA Research Supplement to Promote Diversity in Science to study the role of T cell senescence in pathological effects of type 2 diabetes on atherosclerosis.
2019
The Paul Dudley White International Scholar Award recognizes the highest-ranked abstract from the United States, and is presented at the Annual Meeting of the American Heart Association. In the 2019 Vascular Discovery: from Genes to Medicine Scientific Session, the winning abstract was authored by Dawn M. Fernandez, PhD, titled “Single-Cell Profiling of Atherosclerotic Tissue Identifies T Cell Subsets Associated with Cerebrovascular Events.” In the paper, Dr. Fernandez explains that plaque in arteries may not all be the same, and targeting specific immune cells in plaque may reduce heart attack and stroke risk. These findings also show that T-cells in arterial plaque could signal stroke risk.
Dr. Fernandez’ work was also recognized by the Society for Vascular Surgery who named “Single-Cell Profiling of Atherosclerotic Tissue Identifies T Cell Subsets Associated with Cerebrovascular Events” the best abstract poster presentation in the category of Atherobiology/Novel Models in 2019.
In the News and Media Appearances
Jan 28, 2025. Podcast: Inflammaging Explained: How to fight the hidden cause of aging and disease with Dr. Chiara Giannarelli.
October 2, 2024. Science Blog: SARS-CoV-2 infects coronary arteries, increases plaque inflammation.
November 7, 2023. National Geographic: Now we know how COVID attacks your heart.
September 28, 2023. NYU Langone press release: Study helps explain how COVID-19 heightens risk of heart attack and stroke.
September 28, 2023. NIH News Release: SARS-CoV-2 infects coronary arteries, increases plaque inflammation.
June 13, 2023. MEDPAGETODAY: Recent developments in cardiovascular medicine.
June 8, 2023. EurekAlert! AAAS: Experimental cancer drug may slow inflammation linked to heart disease.
June 8, 2023. The Giannarelli Laboratory Identified a New Use for Experimental Cancer Drug That May Slow Inflammation in Atherosclerosis.
July 21, 2022. Chiara Giannarelli Featured EAS 2022 Plenary Session Speaker “Deep Phenotyping of Atherosclerotic Disease” Symposium Review on Plenary Session 90th European Atherosclerosis Society (EAS) Congress in Milan” EMJ Cardioogyl. 2022; 10[Suppl 3]:02-10.
December 3, 2021. Medscape: COVID Coronary Plaque Infection Confirms CV Risk.
Doctor Radio Sirius X & NYU Langone Health: COVID-19 and cardiovascular disease.
September 11, 2020. Dr. Giannarelli was the keynote speaker at the 2020 Research Retreat hosted by the Department of Pharmacological Sciences at Icahn School of Medicine at Mount Sinai.
October 7, 2019. A team of Mount Sinai researchers that included Dr. Giannarelli was the first to discover single cell immune composition of plaques from stroke patients.
Professional Positions, Awards, and Honors
Dr. Chiara Giannarelli has been recognized with the following professional positions, awards, and recognitions:
- AHA Mentor for the Hispanic Serving Institutions (HSI) Scholar Program (09/2022-04/2024)
- Dr. Martin Morad Lectureship in Cardiovascular Research Award, IACS-NAS conference, Tampa, Florida (2023)
- Fellow of the American Heart Association (FAHA), conferred by the Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) (2023)
- Jeffrey M. Hoeg Arteriosclerosis, Thrombosis, and Vascular Biology Award for Basic Science and Clinical Research, American Heart Association’s Council on Arteriosclerosis, Thrombosis and Vascular Biology (2024)
- Kroc Lecturer, University of Washington’s Diabetes and Metabolism Seminar Series (2024/2025)